A recent article has been published stating that EPA is superior to combinations of EPA and DHA in treating cardiovascular disease (1). The conclusion was drawn based on analyzing…
The primary benefits of omega-3s come from their ability to resolve inflammation through the hormones they generate. The two omega-3s that have been the most widely studied for…
Two recent meta-analysis studies published by the same lead author have stated the conclusion that omega-3 fatty acids have little, if any, benefit in treating cardiovascular…
Recently the FDA has allowed an expanded drug use for Vascepa® to reduce cardiovascular events in subjects with established heart disease and triglyceride levels greater than 150…
Subscribe our newsletter for latest news.
Let's stay updated!